Permanent sensorineural deafness in a patient with chronic myelogenous leukemia secondary to intracranial hemorrhage.

about

Permanent sensorineural deafness in a patient with chronic myelogenous leukemia secondary to intracranial hemorrhage.

Item

http://www.wikidata.org/entity/Q42787888

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Permanent sensorineural deafne ...... ry to intracranial hemorrhage.

@en

Permanent sensorineural deafne ...... ry to intracranial hemorrhage.

@nl

type

Item

label

Permanent sensorineural deafne ...... ry to intracranial hemorrhage.

@en

Permanent sensorineural deafne ...... ry to intracranial hemorrhage.

@nl

prefLabel

Permanent sensorineural deafne ...... ry to intracranial hemorrhage.

@en

Permanent sensorineural deafne ...... ry to intracranial hemorrhage.

@nl

P1476

Permanent sensorineural deafne ...... ry to intracranial hemorrhage.

@en

P2093

Adnan Hussain

http://www.w3.org/2001/XMLSchema#string

Levin Miles

http://www.w3.org/2001/XMLSchema#string

Michael Wax

http://www.w3.org/2001/XMLSchema#string

Sakshi Kapur

http://www.w3.org/2001/XMLSchema#string

P2860

Sudden bilateral deafness from hyperleukocytosis in chronic myeloid leukemia.

Nilotinib: a second-generation tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia.

Subdural hematomas in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving imatinib mesylate in conjunction with systemic and intrathecal chemotherapy.

A case of subdural hematoma in patient with chronic myeloid leukemia treated with high-dose imatinib mesylate.

Acquired von Willebrand factor abnormalities in myeloproliferative disorders and other hematologic diseases: a retrospective analysis by a single institution.

Therapeutic leukapheresis in hyperleukocytic leukaemias--the experience of a tertiary institution in Singapore.

Sudden hearing loss in chronic myelogenous leukaemia implicating the hyperviscosity syndrome.

Irreversible sensorineural hearing loss due to Imatinib.

Neurological complications of chronic myeloid leukaemia: any cure?

Chronic myeloid leukemia presenting with visual and auditory impairment in an adolescent: an insight to management strategies.

P304

894141

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2013/894141

http://www.w3.org/2001/XMLSchema#string

P478

2013

http://www.w3.org/2001/XMLSchema#string

P577

2013-12-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259457514

http://www.w3.org/2001/XMLSchema#string

P698

24367730

http://www.w3.org/2001/XMLSchema#string

P932

3866831

http://www.w3.org/2001/XMLSchema#string